Article

Improved Pharma has upgraded its analytical capabilities by installing a fully automated dissolution system, featuring the Agilent 708-DS apparatus and 850-DS autosampler. This advancement improves the company's ability to conduct controlled and reproducible dissolution testing, essential for drug development.

The system reduces variability and aids in the mechanistic interpretation of dissolution experiments, enhancing formulation screening and stability studies. This investment aims to provide rapid, data-driven decision-making for clients.